Hereditary immunologic disorders caused by pyrin and cryopyrin

Current Allergy and Asthma Reports

Volumn 7, Issue 5, 2007, Pages 323-330

  Hoffman, Hal M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; COLCHICINE; CORTICOSTEROID; CRYOPYRIN PROTEIN; CYTOPLASM PROTEIN; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTEIN NLRP3; PYRIN PROTEIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; CINCA SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE FUNCTION; GENE MUTATION; GENETIC CODE; GENETIC CONSERVATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; MOLECULAR EVOLUTION; MUCKLE WELLS SYNDROME; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PHYSICAL EXAMINATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNE DISEASES; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; HUMANS;

EID: 34548476041     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0049-4     Document Type: Review

References (55)

1. Austen KF: Inborn and acquired abnormalities of the complement system of man. Johns Hopkins Med J 1971, 128:57-74.
2. Curnutte JT, Babior BM: Chronic granulomatous disease. Adv Hum Genet 1987, 16:229-297.
3. Conley ME: Primary immAnodeficiencies: a flurry of new genes. Immunol Today 1995, 16:313-315.
4. Bonilla FA, Geha RS: 2. Update on primary immunodeficiency diseases. J Allergy Clin Immunol 2006, 117:S435-441.
5. Brydges S, Kastner DL: The systemiI autoinflammatory diseases: inborn errors of the innate immune system. Curr Top Microbiol Immunol 2006, 305:127-160.
6. French FMF Consortium: A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat Genet 1997, 17:25-31.
7. International FMF Consortium: Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997, 90:797-807.
8. Hoffman HM, Mueller JL, Broide DH, et al.: Mutation of a new gene encoding a putative pyrin-like protein cause familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001, 29:301-305.
9. Beutler B: The TollAlike receptors: analysis by forward genetic methods. Immunogenetics 2005, 57:385-392.
10. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
11. Harton AA, Linhoff MW, Zhang J, Ting JP: Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol 2002, 169:4088-4093.
12. InoIara N, Nunez G: NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003, 3:371-382.
13. TschApp J, Martinon F, Burns K: NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003, 4:95-104.
14. Bertin J, DiSteAano PS: The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ 2000, 7:1273-1274.
15. Ting JP, Kastner DL, Hoffman HM: CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol 2006, 6:183-195.
16. Ausubel FM: Are innate immune signaling pathways in plants and animals conserved? Nat Immunol 2005, 6:973-979.
17. Belkhadir Y, Subramaniam R, Dangl JL: Plant disease resistance protein signaling: NBS-LRR proteins and their partners. Curr Opin Plant Biol 2004, 7:391-399.
18. da Silva Correia J, Miranda Y, Leonard N, Ulevitch R: SGT1 is essential for Nod1 activation. Proc Natl Acad Sci U S A 2007.
19. Martinon F, Tschopp J: NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005, 26:447-454.
20. Ting JP, Trowsdale J: Genetic control of MHC class II expression. Cell 2002, 109(Suppl):S21-33.
21. Swanberg M, Lidman O, Padyukov L, et al.: MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005, 37:486-494.
22. Rosenstiel P, Till A, Schreiber S: NOD-like receptors and human diseases. Microbes and Infection 2007, In press.
23. Jin Y, Mailloux CM, Gowan K, et al.: NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007, 356, 1216-1225.
24. Hoffman HM, Gregory SG, Mueller JL, et al.: Fine structure mapping of CIAS1: Identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum Genet 2003, 112:209-216.
25. Hoffman HM, Wanderer AA, Broide DH: Familial cold autoinflammatory syndrome: Phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 2001, 108:615-620.
26. Muckle TJ: The 'Muckle-Wells' syndrome. Br J Dermatol 1979, 100:87-92.
27. Prieur AM, Griscelli C, Lampert F, et al.: A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl 1987, 66:57-68.
28. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF: Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004, 50:607-612.
29. Aksentijevich I, Nowak M, Mallah M, et al.: De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002, 46:3340-3348.
30. Hentgen V, Despert V, Lepretre AC, et al.: Intrafamilial variable phenotypic expression of a CIAS1 mutation: From Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome. J Rheumatol 2005, 32:747-751.
31. Feldmann J, Prieur AM, Quartier P, et al.: Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002, 71:198-203.
32. Aksentijevich I, D Putnam C, Remmers EF, et al.: The clinical continuum of cryopyrinopathies: Novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 2007, 56:1273-1285.
33. Anderson JP, Mueller JL, Rosengren S, et al.: Structural, expression, and evolutionary analysis of mouse CIAS1. Gene 2004, 338:25-34.
34. Manji GA, Wang L, Geddes BJ, et al.: PYPAF1: A PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kB. J Biol Chem 2002, 277:11570-11575.
35. Kummer JA, Broekhuizen R, Everett H, et al.: Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 2007, 55:443-452.
36. Rosengren S, Hoffman HM, Bugbee W, Boyle DL: Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium. Ann Rheum Dis. 2005, 64:708-714.
37. Martinon F, BurAs K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10:417-426.
38. Grahames CB, Michel AD, Chessell IP, Humphrey PP: Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol 1999, 127:1915-1921.
39. Mariathasan S, Monack DM: Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 2007, 7:31-40.
40. Martinon F, Agostini L, Meylan E, Tschopp J: Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 2004, 14:1929-1934.
41. Pan Q, Mathison J, Fearns C, et al.: MDP-induced interleukin-1(beta) processing requires Nod2 and CIAS1/NALP3. J Leukoc Biol 2007, Epub ahead of print.
42. Agostini L, Martinon F, Burns K, et al.: NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004, 20:319-325.
43. Stack JH, Beaumont K, Larsen PD, et al.: ICE/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from FCAS patients. J Immunol 2005, 175:2630-2634.
44. Dowds TA, Masumoto J, Chen FF, et al.: Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003, 302:575-580.
45. Fujisawa A, Kambe N, Saito M, et al.: Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells. Blood 2006.
46. Goldbach-Mansky R, Dailey NJ, Canna SW, et al.: Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006, 355:581-592.
47. Hawkins PN, Lachmann HJ, McDermott MF: Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003, 348:2583-2584.
48. Hoffman HM, Rosengren S, Boyle DL, et al.: Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004, 364:1779-1785.
49. Kastner DL: Familial Mediterranean fever:, the genetics of inflammation. Hosp Pract (Off Ed) 1998, 33:131-134, 139-140, 143-136 passim.
50. Samuels J, Ozen S: Familial Mediterranean fever and the other autoinflammatory syndromes: Evaluation of the patient with recurrent fever. Curr Opin Rheumatol 2006, 18:108-117.
51. Stojanov S, Kastner DL: FamiliGl autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005, 17:586-599.
52. Schaner P, Richards N, Wadhwa A, et al.: Episodic evolution of pyrin in primates: Human mutations recapitulate ancestral amino acid states. Nat Genet 2001, 27:318-321.
53. Chae JJ, Wood G, Masters SL, et al.: The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A 2006, 103:9982-9987.
54. Papin S, Cuenin S, Agostini L, et al.: The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007.
55. Niel E, Scherrmann JM: Colchicine today. Joint Bone Spine 2006, 73:672-678.